Last CNY13.69 CNY
Change Today -0.67 / -4.67%
Volume 17.1M
600513 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

jiangsu lianhuan pharmaceu-a (600513) Snapshot

Open
CNY13.91
Previous Close
CNY14.36
Day High
CNY14.83
Day Low
CNY13.66
52 Week High
07/10/14 - CNY14.90
52 Week Low
07/15/13 - CNY9.30
Market Cap
2.1B
Average Volume 10 Days
8.1M
EPS TTM
CNY0.26
Shares Outstanding
156.7M
EX-Date
06/19/14
P/E TM
52.3x
Dividend
CNY0.08
Dividend Yield
0.55%
Current Stock Chart for JIANGSU LIANHUAN PHARMACEU-A (600513)

Related News

No related news articles were found.

jiangsu lianhuan pharmaceu-a (600513) Related Businessweek News

No Related Businessweek News Found

jiangsu lianhuan pharmaceu-a (600513) Details

Jiangsu Lianhuan Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company offers various APIs and intermediates. Its primary products include steroid hormone, antibiotic, antihistamine, cardiovascular, anti-allergic, and urological surgery drugs, such as felodipine capsules sustained-release, sertraline hydrochloride capsules, balofloxacin tablets, epristeride tablets, danazol capsules, metformin gliclazide tablets, and others. The company is based in Yangzhou, China.

jiangsu lianhuan pharmaceu-a (600513) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jiangsu lianhuan pharmaceu-a (600513) Key Developments

Jiangsu Lianhuan Pharmaceutical Co.,Ltd. Reports Earnings Results for 2013

Jiangsu Lianhuan Pharmaceutical Co.,Ltd. reported earnings results for 2013. For the period, the company reported basic earnings per share was CNY 0.24 and weighted average return on net assets was 9.78%.

Jiangsu Lianhuan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter of 2014

Jiangsu Lianhuan Pharmaceutical Co.,Ltd. reported earnings results for the first quarter of 2014. For the period, the company reported basic earnings per share was CNY 0.06 and weighted average return on net assets was 2.45%.

Jiangsu Lianhuan Pharmaceutical Co.,Ltd., Annual General Meeting, May 17, 2014

Jiangsu Lianhuan Pharmaceutical Co.,Ltd., Annual General Meeting, May 17, 2014., at 09:00 China Standard Time. Agenda: To consider annual report of 2013 and it abstract; to consider profit distribution scheme for 2013; and to consider the proposal of renewing engagement of accounting firm and its remuneration.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600513:CH CNY13.69 CNY -0.67

600513 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600513.
View Industry Companies
 

Industry Analysis

600513

Industry Average

Valuation 600513 Industry Range
Price/Earnings 55.0x
Price/Sales 3.5x
Price/Book 5.5x
Price/Cash Flow 53.0x
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JIANGSU LIANHUAN PHARMACEU-A, please visit www.lhpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.